{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:13:29Z","timestamp":1786994009097,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T00:00:00Z","timestamp":1681603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["64405"],"award-info":[{"award-number":["64405"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.mcp.2023.101914","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T08:35:45Z","timestamp":1682066145000},"page":"101914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evaluation of the immune checkpoint factors in idiopathic membranous nephropathy"],"prefix":"10.1016","volume":"69","author":[{"given":"Roza","family":"Motavalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Soltani-Zangbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Dolati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9823-5454","authenticated-orcid":false,"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Etemadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mcp.2023.101914_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.mcp.2023.101914_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2016070776","article-title":"A proposal for a serology-based approach to membranous nephropathy","volume":"28","author":"De Vriese","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.mcp.2023.101914_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2017.92","article-title":"Treatment of membranous nephropathy: time for a paradigm shift","volume":"13","author":"Ruggenenti","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.mcp.2023.101914_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116923","article-title":"Immune system-mediated cellular and molecular mechanisms in idiopathic membranous nephropathy pathogenesis and possible therapeutic targets","volume":"238","author":"Motavalli","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.mcp.2023.101914_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-018-0478-8","article-title":"Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience","volume":"7","author":"Mamlouk","year":"2019","journal-title":"Journal for immunotherapy of cancer"},{"issue":"6","key":"10.1016\/j.mcp.2023.101914_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneph.2017.34","article-title":"T cells and autoimmune kidney disease","volume":"13","author":"Suarez-Fueyo","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.mcp.2023.101914_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.mcp.2023.101914_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102333","article-title":"Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases","volume":"104","author":"Huang","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.mcp.2023.101914_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.mcp.2023.101914_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01056-8","article-title":"Next generation of immune checkpoint inhibitors and beyond","volume":"14","author":"Marin-Acevedo","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.mcp.2023.101914_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ijc.32785","article-title":"Assessment of the expression of the immune checkpoint molecules PD\u20101, CTLA4, TIM\u20103 and LAG\u20103 across different cancers in relation to treatment response, tumor\u2010infiltrating immune cells and survival","volume":"147","author":"Tu","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.mcp.2023.101914_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","article-title":"Control of peripheral T\u2010cell tolerance and autoimmunity via the CTLA\u20104 and PD\u20101 pathways","volume":"224","author":"Fife","year":"2008","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.mcp.2023.101914_bib13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.mcp.2023.101914_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2020.12070","article-title":"Progress of immune checkpoint LAG-3 in immunotherapy","volume":"20","author":"Shan","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.mcp.2023.101914_bib15","first-page":"269","article-title":"LAG-3 in cancer immunotherapy","author":"Goldberg","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.mcp.2023.101914_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030676","article-title":"TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression","volume":"7","author":"Gao","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mcp.2023.101914_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0022-3565(24)39216-X","article-title":"Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca2+ stores","volume":"293","author":"Kalra","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.mcp.2023.101914_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim\u20103 and its role in regulating anti\u2010tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.mcp.2023.101914_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.23876\/j.krcp.2018.37.3.248","article-title":"Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy","volume":"37","author":"Song","year":"2018","journal-title":"Kidney Res Clin Pract"},{"issue":"2","key":"10.1016\/j.mcp.2023.101914_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001287","article-title":"Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab","volume":"8","author":"Lin","year":"2020","journal-title":"Journal for immunotherapy of cancer"},{"key":"10.1016\/j.mcp.2023.101914_bib21","first-page":"1919","article-title":"Helper T cells in idiopathic membranous nephropathy","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2023.101914_bib22","first-page":"1647","article-title":"Case report: THSD7A-positive membranous nephropathy caused by tislelizumab in a lung cancer patient","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mcp.2023.101914_bib23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ckj\/sfz074","article-title":"Relapse of membranous nephropathy with cancer immunotherapy","volume":"14","author":"Kim","year":"2021","journal-title":"Clinical Kidney Journal"},{"issue":"1","key":"10.1016\/j.mcp.2023.101914_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ckj\/sfz074","article-title":"Relapse of membranous nephropathy with cancer immunotherapy","volume":"14","author":"Kim","year":"2019","journal-title":"Clinical Kidney Journal"},{"issue":"2","key":"10.1016\/j.mcp.2023.101914_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001287","article-title":"Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab","volume":"8","author":"Lin","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"17","key":"10.1016\/j.mcp.2023.101914_bib26","doi-asserted-by":"crossref","first-page":"E2383","DOI":"10.1073\/pnas.1603892113","article-title":"Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood","volume":"113","author":"Klocke","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"15","key":"10.1016\/j.mcp.2023.101914_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158656","article-title":"Activation markers on B and T cells and immune checkpoints in autoimmune rheumatic diseases","volume":"23","author":"Gerasimova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.mcp.2023.101914_bib28","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.4049\/jimmunol.179.11.7466","article-title":"Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles","volume":"179","author":"Menke","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.mcp.2023.101914_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00005-017-0485-3","article-title":"The PD-1\/PD-L1 inhibitory pathway is altered in primary glomerulonephritides","volume":"66","author":"Grywalska","year":"2018","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"2","key":"10.1016\/j.mcp.2023.101914_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00005-017-0485-3","article-title":"The PD-1\/PD-L1 inhibitory pathway is altered in primary glomerulonephritides","volume":"66","author":"Grywalska","year":"2018","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"4","key":"10.1016\/j.mcp.2023.101914_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1440-1681.12555","article-title":"Increased ratio of ICOS(+)\/PD-1(+) follicular helper T cells positively correlates with the development of human idiopathic membranous nephropathy","volume":"43","author":"Shi","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"Preprint","key":"10.1016\/j.mcp.2023.101914_bib32","first-page":"1","article-title":"Role of Tim-3 in regulating tumorigenesis, inflammation, and antitumor immunity therapy","author":"Cao","year":"2021","journal-title":"Cancer Biomarkers"},{"issue":"6","key":"10.1016\/j.mcp.2023.101914_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23248","article-title":"Soluble Tim3 detection by time\u2010resolved fluorescence immunoassay and its application in membranous nephropathy","volume":"34","author":"Chen","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"7","key":"10.1016\/j.mcp.2023.101914_bib34","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.4049\/jimmunol.1100714","article-title":"Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3","volume":"187","author":"Bettini","year":"2011","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.mcp.2023.101914_bib35","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2337\/db11-1591","article-title":"Modulation of redox balance leaves murine diabetogenic TH1 T cells \u201cLAG-3-ing\u201d behind","volume":"61","author":"Delmastro","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.mcp.2023.101914_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2023.101914_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155452","article-title":"Altered Th17\/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy","volume":"141","author":"Motavalli","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.mcp.2023.101914_bib38","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3389\/fimmu.2018.02306","article-title":"Immune checkpoints as therapeutic targets in autoimmunity","volume":"9","author":"Paluch","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850823000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850823000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:17:48Z","timestamp":1760192268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850823000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":38,"alternative-id":["S0890850823000233"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2023.101914","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the immune checkpoint factors in idiopathic membranous nephropathy","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2023.101914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101914"}}